Respiratory Disease Testing Market (Imaging, Spirometry, Peak Flow, Blood Gas, Lung Volume, and other Tests) for Hospitals, Physician Offices and Clinical Laboratories: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global respiratory disease testing market is expected to reach USD 3.1 Billion by 2021, growing at a CAGR of 3.6% between 2016 and 2021.

29-Aug-2016 | Number of pages: 110 | Report Code: ZMR-114 | Report Format : | Status : Published

Abstract

The report provides analysis and forecast for the respiratory disease testing market on a regional and global level. The study covers historic data of 2015 provided along with a forecast from 2016 to 2021 based on revenue (USD billion). The study provides restraints and drivers for the respiratory disease testing market coupled along with the impact they have on the demand over the forecast period. Moreover, the report also covers the analysis of opportunities present in the respiratory disease testing market on a global level.

With the objective to give the users of this report a complete and clear view on the respiratory disease testing market and to better understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the respiratory disease testing market has also been covered. The study provides with a comprehensive market attractiveness analysis, wherein product segments and end-user segments are based on their growth rate, market size, and general attractiveness.

The study provides a clear view on the respiratory disease testing market by segmenting the market based on end-user segment, product segment, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on product segment, the respiratory disease testing market has been segmented into imaging, spirometry, peak flow, blood gas, lung volume, and other tests. Based on the end-user segment, the respiratory disease testing market has been segmented into physician offices, hospitals, and clinical laboratories. The regional segmentation includes the current and forecast demand for Latin America, North America, Asia-Pacific, Europe, and the Middle East and Africa with its further bifurcation into major countries including Germany, France, UK, China, Japan, India, U.S. AND Brazil.

The report also includes comprehensive profiles of end players such as ndd Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. GE Healthcare and others. The thorough description of players includes parameters such as company overview, business, financial overview, and recent developments of the company.

This report segments the global respiratory disease testing market as follows:

Global Respiratory Disease Testing Market: Product Segment Analysis

  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Tests

Global Respiratory Disease Testing Market: End-user Segment Analysis

  • Hospitals
  • Physician Offices
  • Clinical Laboratories

Global Respiratory Disease Testing Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Companion Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1127 | Report Format:

Global Companion Diagnostics Market: Overview A diagnostic test used as an associate to the therapeutic drug in order to determine its usefulness to the patient is known as companion diagnostics. This technology is useful for improving therapeutic treatment available based on the individual. Com...Read More

Atrial Fibrillation Surgery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1102 | Report Format:

Global Atrial Fibrillation Surgery Market: Overview The heart contracts and relaxes in a regular interval of time. There are certain cells in the heart that impulse electric signals and cause the heart to contract and pump blood. These electrical signals can see and record with the help of elect...Read More

Clinical Trial Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1098 | Report Format:

Global Clinical Trial Imaging Market: Overview The use of the imaging systems in the non-clinical and clinical trials is been carried out since long. The clinical imaging is majorly used to obtain human physiology or anatomy informations which are undeniable as well as interpretable. The use of ...Read More

Atomic Spectroscopy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1093 | Report Format:

Global Atomic Spectroscopy Market: Overview A study of absorption and emission of the electromagnetic radiation by the atom is known as atomic spectroscopy. Radiations are emitted when electrons are excited and move from one valence bond to lower valence bond. Absorption of energy takes place wh...Read More

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1090 | Report Format:

Global Breast Biopsy Market: Overview A breast biopsy is a procedure used for the screening and diagnosis of breast cancer. This is not only limited to cancer but also other ailments of the breast such as a lump in the breast and others. In this procedure, a sample of the breast tissue is remove...Read More

Choose License Type:
Latest Published Reports

View All Published Reports